Sky Century Investment (SKYI) Receivables - Other (2013 - 2014)
Sky Century Investment (SKYI) posted quarterly Receivables - Other of -$40195.0 for Q3 2014, down 55.61% quarter-over-quarter from -$25830.0 in Q2 2014.
Sky Century Investment (SKYI) Receivables - Other (2013 - 2014) Analysis & Trends
Sky Century Investment (SKYI) has reported Receivables - Other for 2 consecutive years, with -$40195.0 the latest figure, recorded in Q3 2014.
- In Q3 2014, Receivables - Other changed N/A year-over-year to -$40195.0; the TTM figure through Aug 2014 stood at -$40195.0 (changed N/A YoY), while the FY2014 annual figure was -$31765.0, down 129.42% from the prior year.
- Receivables - Other declined to -$40195.0 in Q3 2014 per SKYI's latest filing, from -$25830.0 in the prior quarter.
- Across five years, Receivables - Other topped out at -$13846.0 in Q2 2013 and bottomed at -$40195.0 in Q3 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Sky Century Investment | 393,547.71 | 393,283.71 | 26,045.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Aug 31, 2014 | -40,195.00 |
| Aug 31, 2014 | -40,195.00 |
| May 31, 2014 | -25,830.00 |
| May 31, 2014 | -25,830.00 |
| May 31, 2013 | -13,846.00 |
| May 31, 2013 | -13,846.00 |